ダウンロード数: 152
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
20_0001.pdf | 781.32 kB | Adobe PDF | 見る/開く |
タイトル: | シンチカメラによる研究 "197Hg-クロルメロドリンによる腎シンチグラフィーの検討" |
著者: | 豊田, 尚武 後藤, 薫 |
著者名の別形: | Toyoda, Naotake Gotoh, Kaoru |
発行日: | Jan-1974 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 20 |
号: | 1 |
開始ページ: | 1 |
終了ページ: | 5 |
抄録: | The [203]Hg-labelled Chlormerodrin has been mainly used for kidney scintigraphy. However, [197]Hg-labelled Chlormerodrin has the possibilities of repeated examinations and application to pediatrics because [197]Hg has shorter half-life and less radiation exposure to patients than [203]Hg. Here fundamental and clinical investigation on [197]Hg-Chlormerodrin for kidney scanning agent was performed with an idea that this scanning agent will be widely used in place of [203]Hg. Chlormerodrin in the near future. Total 20 cases were examined using [197]Hg-Chlormerodrin and these results were compared with those of [203]Hg-Chlormerodrin. There were some differences in conditions of taking the scintigrams, but no differences on obtained scintigrams were recognized. The most suitable time period for taking the scintigrams with [197]Hg-Chlormerodrin was 3 to 24 hours after the intravenous administration. The remaining radioactivity of [197]Hg-Chlormerodrin in kidney 10 days after the intravenous administration was not observed because of its short physical halflife of 2.7 days and excretion in urine. The radioactivities of [197]Hg-Chlormerodrin in the urine decreased as 100: 10 : 1 = in the first 24 hours: the second 24 hrs. : the third 24 hrs. No radioactivity was recognized after the third day. |
URI: | http://hdl.handle.net/2433/121614 |
出現コレクション: | Vol.20 No.1 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。